Key Finding
No strong consistent positive evidence pattern was detected.
Interventions with strongest consistent evidence
Strongest consistent evidence
Interpretation
The current evidence does not yet show a clear consistent-benefit pattern.
Cardiometabolic Risk in Diabetes: Blood Pressure, Cholesterol, and Heart Outcomes
Evidence related to cardiometabolic risk
Evidence related to blood pressure, lipid profile, cardiovascular risk, cardiovascular events, and cardiometabolic risk markers in diabetes.
Build your Evidence Workspace
Save evidence about the topics you care about.
9
Studies
17
Evidence Pairs
Moderate Research Support
Relationship Confidence: 57/100
Evidence Intelligence™
Evidence Summary
A structured summary of where the evidence is strongest, mixed, or still emerging.
Executive Summary
Cardiometabolic Risk evidence appears to center on Metformin.
Among 9 indexed studies and 4 interventions, the strongest signals are summarized from the available evidence. Resistance training has been studied often, while Metformin appears to have stronger current evidence signals.
- No strong consistent positive evidence pattern was detected.
- Some evidence is positive, but results are not consistent across all studies.
- Early findings are encouraging, but stronger trials are needed.
Caution
This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.
Evidence Snapshot
9
Studies
4
Interventions
8
Outcomes
0
Strong evidence signals
1
Mixed evidence areas
Key Findings
Key patterns and insights identified across the research landscape
Moderate positive signal
SGLT2 inhibitors may improve All-cause mortality
SGLT2 inhibitors → All-cause mortality
Across 2 studies, SGLT2 inhibitors shows a moderate positive signal for All-cause mortality.
2 studies
EvidenceScore™: 69/100
Neutral signal
Exercise therapy shows limited or neutral effect on HDL cholesterol
Exercise therapy → HDL cholesterol
Across 1 study, Exercise therapy shows a neutral signal for HDL cholesterol.
1 studies
EvidenceScore™: 59/100
Neutral signal
Exercise therapy shows limited or neutral effect on LDL cholesterol
Exercise therapy → LDL cholesterol
Across 1 study, Exercise therapy shows a neutral signal for LDL cholesterol.
1 studies
EvidenceScore™: 59/100
Neutral signal
Exercise therapy shows limited or neutral effect on lipid profiles
Exercise therapy → lipid profiles
Across 1 study, Exercise therapy shows a neutral signal for lipid profiles.
1 studies
EvidenceScore™: 59/100
Strong positive signal
Exercise therapy shows strong evidence for improving Systolic blood pressure
Exercise therapy → Systolic blood pressure
Across 1 study, Exercise therapy shows a strong positive signal for Systolic blood pressure.
1 studies
EvidenceScore™: 59/100
Supporting Evidence
Mixed or conflicting evidence
Some evidence is positive, but results are not consistent across all studies.
Areas where results are mixed
Why it matters
Mixed results suggest effects may depend on population, comparator, duration, or study design.
Interpretation
Resistance training is mixed in the currently indexed evidence.
Caution
Some supporting studies reported neutral, negative, or mixed findings.
Top entities
Resistance training
SGLT2 inhibitors
Resistance training
3 studies
EvidenceScore™
59/100
ConsistencyScore™
67/100
Why this appears here
Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results PresentNegative Results Present
Evidence basis: 17 evidence pairs - 9 studies
Promising but understudied
Early findings are encouraging, but stronger trials are needed.
Promising areas needing more evidence
Why it matters
Promising signals can guide further review, but they should not be treated as settled evidence.
Interpretation
SGLT2 inhibitors may have a beneficial signal, but the evidence base is still developing.
Caution
Current support is limited by study volume, RCT depth, or evidence strength.
Top entities
SGLT2 inhibitors
Metformin
SGLT2 inhibitors
3 studies
EvidenceScore™
69/100
ConsistencyScore™
49/100
Why this appears here
Positive effect signalLimited study volumeEmerging Or Limited Strength
Evidence basis: 9 evidence pairs - 5 studies
Question Highlights
Quick answers to the most important questions supported by the available evidence.
Does SGLT2 inhibitors improve all-cause mortality?
SGLT2 inhibitors may improve All-cause mortality.
Moderate evidence is based on 2 supporting studies.
Some evidence reported benefits while other evidence found little or no effect.
View full answerExplore the Evidence
The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.
Questions Answered by the Evidence
Does SGLT2 inhibitors improve all-cause mortality?
intervention effectivenessModerate Evidence
SGLT2 inhibitors may improve All-cause mortality.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Evidence caveat: Some evidence reported benefits while other evidence found little or no effect.
Ranked evidence signals
- 1
SGLT2 inhibitors
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
- Only a small number of supporting studies are available.
- Population details are unavailable.
Does SGLT2 inhibitors improve systolic blood pressure?
intervention effectivenessEmerging Evidence
Current evidence does not show a clear benefit of SGLT2 inhibitors for Systolic blood pressure.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
SGLT2 inhibitors
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does SGLT2 inhibitors improve hdl cholesterol?
intervention effectivenessEmerging Evidence
Current evidence does not show a clear benefit of SGLT2 inhibitors for HDL cholesterol.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
SGLT2 inhibitors
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Metformin improve systolic blood pressure?
intervention effectivenessEmerging Evidence
Metformin appears to improve Systolic blood pressure.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Metformin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Metformin improve total cholesterol?
intervention effectivenessEmerging Evidence
Current evidence does not show a clear benefit of Metformin for Total cholesterol.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Metformin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Metformin improve ldl cholesterol?
intervention effectivenessEmerging Evidence
Metformin appears to improve LDL cholesterol.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Metformin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Exercise therapy improve systolic blood pressure?
intervention effectivenessEmerging Evidence
Exercise therapy appears to improve Systolic blood pressure.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Exercise therapy
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Metformin improve hdl cholesterol?
intervention effectivenessEmerging Evidence
Metformin appears to improve HDL cholesterol.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Metformin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Evidence summary for AI and search
Among 9 indexed studies and 4 interventions, the strongest signals are summarized from the available evidence. Resistance training has been studied often, while Metformin appears to have stronger current evidence signals.
- No strong consistent positive evidence pattern was detected.
- Some evidence is positive, but results are not consistent across all studies.
- Early findings are encouraging, but stronger trials are needed.
Supporting Research
Selected studies that best represent the evidence behind this topic.
Structured exercise improves weight loss after gastric bypass surgery
Representative
Interventions:
Outcomes:
SGLT2 inhibitors improve kidney and cardiovascular outcomes across albuminuria levels
Representative
Interventions:
Outcomes:
Click any study to view the full research summary, or click interventions and outcomes to filter Evidence Explorer.
Continue exploring
Related evidence briefs
Evidence Tracker
Track Cardiometabolic Risk in Diabetes: Blood Pressure, Cholesterol, and Heart Outcomes evidence
Save this evidence topic and revisit it as new studies are added.